Dr. Emil Katz has PhD in Immunology from The Weizmann Institute of Science, Israel. He has more than 25 years experience in the healthcare field. Strong entrepreneurial background: successfully guided the development of three start-up companies including "Diatech Diagnostics", which subsequently merged into Healthcare Technologies and is traded on NASDAQ. Prior to founding Novamed: CEO of "Israel Chemicals-Pharma" Division.
Dr. Emil Katz has PhD in Immunology from The Weizmann Institute of Science, Israel. He has more than 25 years experience in the healthcare field. Strong entrepreneurial background: successfully guided the development of three start-up companies including "Diatech Diagnostics", which subsequently merged into Healthcare Technologies and is traded on NASDAQ. Prior to founding Novamed: CEO of "Israel Chemicals-Pharma" Division.